![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3432ccdf8f4a517f4e7ed52239531f7f.svg) | Apafant | IC50 | 40.0 [1], 50.0 [2], 200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_51335301c161212b392b3ff071f7e66f.svg) | 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | IC50 | 6.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_51335301c161212b392b3ff071f7e66f.svg) | 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | Ki | 3.2 [1], 6.0 [2], 6.1 [3], 6.3 [4] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e38b575c7f91c199723f821299fbe925.svg) | (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e38b575c7f91c199723f821299fbe925.svg) | (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | Ki | 9.0 [1], 14.3 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_9dfec753054c5bc7b943e974f42c99a4.svg) | 5-(4-Methoxyphenyl)-N-(1-methyl-4-(3-pyridinyl)butyl)-2,4-decadienamide | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_64cd642ddc8fb9110c81512faa847479.svg) | Loratadine | IC50 | 50000.0 [1], 135000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_11f07f2164996353041f0d221b98db68.svg) | Modipafant racemate | IC50 | 13.0 [1], 31.3 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_21ba99e3f48f143c3cad4f232cbfd429.svg) | Respatadine | IC50 | 610.0 [1], 840.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_2c22a859a69900eda205a7db7d7c0814.svg) | 5-[4-[2-(3,4,5-Trimethoxyphenyl)ethyl]phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 40.0 [1], 60.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3e208ff05c3a466f013c0aa6e61934ea.svg) | (2R,5R)-2,5-Bis(3,4,5-trimethoxyphenyl)oxolane | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3e208ff05c3a466f013c0aa6e61934ea.svg) | (2R,5R)-2,5-Bis(3,4,5-trimethoxyphenyl)oxolane | Ki | 103.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_9cf7ef37a4dafe2a547db35bbc4f6295.svg) | 2-[3-Methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | Ki | 59.0 [1], 116.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e74e1e5198e85af3b4bcbbaa908e6c37.svg) | 4-(2-Chlorophenyl)-2-iodo-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | IC50 | 370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_0a9c423617696738f5fe7728a0ca4288.svg) | 1-Iphtf | Ki | 1.85 [1], 2.9 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_b18845a14a449aff3e2d1e2678c23604.svg) | Potassium;3-[3-(2-oxopropylsulfonyl)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenoxy]propyl hydrogen phosphate | Ki | 110.0 [1], 174.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_005b35bf7541532536ae74e1ccd1ee81.svg) | (4R)-5-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonyl-4-methylpentan-1-ol | Ki | 3.72 [1], 5.26 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_eeb662373883d40fe3907fed5d3dbe72.svg) | (4S)-5-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonyl-4-methylpentan-1-ol | Ki | 2.86 [1], 3.7 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e806cc66b17e61a2090f958a041ce293.svg) | N-Cyclohexyl-N-methyl-4-[(2-methylbenzimidazol-1-yl)methyl]benzenesulfonamide | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_4438da061a6d769a486057eb1d6becf4.svg) | (5S)-2-[4-[2-(Benzenesulfonyl)ethoxy]-3-methoxy-5-propylsulfonylphenyl]-5-(3,4,5-trimethoxyphenyl)oxolane | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_4438da061a6d769a486057eb1d6becf4.svg) | (5S)-2-[4-[2-(Benzenesulfonyl)ethoxy]-3-methoxy-5-propylsulfonylphenyl]-5-(3,4,5-trimethoxyphenyl)oxolane | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_6c5a78e8ca55529a3f6c3b506ecb26d6.svg) | Clotrimazole | Ki | 22635.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_aaf3fd234b0a01481a8025379dd6f784.svg) | Chlorpheniramine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_bfa92afabe22373d293e574beb10dd93.svg) | Ginkgolide-B | IC50 | 128.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e95e396dbd6acec352ead4f1e6f5b329.svg) | Brotizolam | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_06036305afd49dd9a843330815b2b25d.svg) | Cilostamide | Ki | 1917.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_7c960788adc8929eee3f9b1ec68725a3.svg) | Rupatadine | IC50 | 3700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_519a2638ccb9271cc8240e5ab73303dc.svg) | Azatadine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_19b6704d2189bcc7238e21e3b4424b09.svg) | Lexipafant | Ki | 0.38 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_971aa60e22dca9c3eb4ddcbec232d308.svg) | 5-[3-[7-(2-Chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-4-yl]prop-2-ynyl]phenanthridin-6-one | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_ae73231b4094011e9ed6673d589df123.svg) | Tulopafantum | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_dabb639eb5b7d9746a181a9707adfca0.svg) | Orvepitant | Ki | 2270.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_369fce2496606ee080c98f43376a2d17.svg) | (2r)-2-(Acetyloxy)-3-(Hexadecyloxy)propyl 2-(Trimethylammonio)ethyl Phosphate | IC50 | 0.28 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_bb6a3c54dcfac735095bfc4e9999d1d6.svg) | 3-[[2-[2-(4-Chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxy-1-methylurea | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_c03b9f393ad321d4fec1f86424a52e55.svg) | [4-(3-Phenylpropyl)piperazin-1-yl]-[(4R)-2-pyridin-3-yl-1,3-thiazolidin-4-yl]methanone | IC50 | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_700e85fe5d74c80286817c52365902d5.svg) | CID 46897162 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_5601f6c9f53679c3d987fa1daabb532b.svg) | 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]butan-1-one | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_83c8bd3995f206ab12d733b14b538061.svg) | 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]propan-1-one | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e9edaa57ddd7cefb20559656f374a1fa.svg) | N-(4-1H-Imidazol-1-yl)butyl-2-(1-methylethyl)-11-oxo-11H-pyrido(2,1b)quinazoline-8-carboxamide | IC50 | 3500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_d25a9190e828142a73528676b76c0461.svg) | ABT-491 free base | Ki | 0.57 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_79ac5d4b4d079c06fbc9113def59063c.svg) | (2R,3R,4R,5S)-2,5-Bis-(3,4-dimethoxy-phenyl)-3,4-dimethyl-tetrahydro-furan | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_6ca3c072aca1db580c5320fc6ddb47b9.svg) | N-[(2S)-1-Ethoxy-4-methylpentan-2-yl]-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzenesulfonamide | IC50 | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_ddd1485f2b735d0a9dd4ed16d620cccf.svg) | 5-(2-Fluoro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3813698f36944ecf3782540ee170012b.svg) | 11-Oxo-2-propan-2-yl-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 350.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_13eb47c4a93100db5e7bb3847c917492.svg) | 2-Methyl-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_f367ddcf0a152f0632b2e868a7b690ec.svg) | 2-Methoxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_037ee7c30ab48603c09961d1f775b496.svg) | 11-Oxo-2-propan-2-yloxy-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3236ce4cf5e2e9bf54e4f01a3a94222b.svg) | 11-Oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_2399c844072f224d74bf65c546ab5bf9.svg) | 2-Bromo-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_3bf1fdcf6f8f84597d63c1e65141f7d5.svg) | 2-Hydroxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_a46c781d1da8aff9bb6664c5130ebc8b.svg) | 11-Oxo-2-propan-2-yl-N-(4-pyridin-2-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_1fb0251df1d2dbe8acca541d72155802.svg) | 11-Oxo-2-propan-2-yl-N-(7-pyridin-3-ylheptyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_7c0d2d517fb26f876aa0d4e5967a2c51.svg) | 11-Oxo-2-propan-2-yl-N-(4-pyrimidin-5-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 450.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_aac6fce92d932240d3f758382150f5ee.svg) | 3-Methoxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_c62ebdda9eb4672398825f0eb068f4bc.svg) | 3-Chloro-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_f2555db2caaf0f659f27cd77bfb9dcfb.svg) | N-(2-Methyl-5-pyridin-3-ylpentan-2-yl)-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_1e3139046e336f5655f80987ba0b4a09.svg) | N-Formyl Desloratadine | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_8f70d9e1fb394795993b702910c615cd.svg) | 1-[4-(13-Methoxy-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]ethanone | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_204d40ab15cc94080a98e23f842706b4.svg) | 1-[4-(2-Tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)piperidin-1-yl]ethanone | IC50 | 41000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_be40869221ac168e96a6d7848e197295.svg) | 2,5-Bis-(3,4,5-trimethoxy-phenyl)-tetrahydro-furan | IC50 | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_fb0a756814da600f8bc7bc22864123a2.svg) | 1-(2,2-Dimethylpropyl)-5-[5-(2-hydroxypropan-2-yl)-2-methylphenyl]-3-methylimidazo[4,5-b]pyridin-2-one | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_cc404f6bab2eb447440b145a7562aa9e.svg) | SDZ-62-434 free | IC50 | 7500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_8c9a6c2a5129ef7efa54e78448e43344.svg) | N-[4,6-Dimethoxy-2-(3-morpholin-4-ylpropylamino)pyrimidin-5-yl]-5-[(3,3,6-trimethyl-1,2-dihydroinden-5-yl)oxy]furan-2-carboxamide | Ki | 1060.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_98b6157b08e134b645acbcd2ecd3347e.svg) | (E)-3-(1-Butyl-4-methoxynaphthalen-2-yl)-N-[(2S)-5-pyridin-3-ylpentan-2-yl]prop-2-enamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_29d766d74060045451747736cc71e071.svg) | 5-p-Tolyl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_70f4d387295d509bdfee04f0d0b830b7.svg) | Diallyl-[4-(2,3-dihydro-imidazo[2,1-a]isoquinolin-5-yl)-benzyl]-amine | IC50 | 9200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_d5bcf4f3fa5fc09f64e6a7ccbc65c0ae.svg) | 4-[[4-(2,3-Dihydroimidazo[2,1-a]isoquinolin-5-yl)phenyl]methyl]thiomorpholine | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_e6268f8acd3443f0d9965a426e844dde.svg) | 1-[3-(3-Morpholin-4-ylpropoxy)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylpropan-2-one | Ki | 2.5 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_c851be7f704bbb3c33edf5d7ece5c954.svg) | 5-(4-Pyrrolidin-1-ylmethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 59400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_cef75abf071475b2b91435a9fcb698c5.svg) | Dicyclohexyl-[4-(2,3-dihydro-imidazo[2,1-a]isoquinolin-5-yl)-benzyl]-amine | IC50 | 13100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_d6ef276338789d2c275d5a88fba1f3a9.svg) | 5-Phenyl-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 11200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_84d1c03a6c998bcd2b4c18c667efe33b.svg) | 5-Pyridin-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 47900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_5bf58c99da39f6012c3bd84d53043284.svg) | 5-Thiophen-2-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 15200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_5caa32834a0567c4013b2a226e1793b2.svg) | 5-(3,4-Dimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 22000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_ddcf7686b01673dedd81a465d14b445e.svg) | 5-(4-Tert-Butylphenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_08f3183f8765d3cb67afe9cc60b2e2b7.svg) | 5-(4-Morpholin-4-ylmethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 2800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_f530982e3e487ff123c38a3f4e1e877f.svg) | 5-Furan-2-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_987a8d13e5c0a96e36d7d7640a75968f.svg) | 5-(4-Fluoro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 14200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_518ee62ff2010bfc948494ca6e7ce464.svg) | 5-(3,4,5-Trimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_c87efd7a6551c3fb2360421782c3f080.svg) | 5-(4-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 37200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_b7a1246a526cebc13c484f0e016032b7.svg) | 5-Biphenyl-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_2f7ca4a29b34137b029cf07468eaa78b.svg) | 5-(2-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 8100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_0ef41dd6380f571115a3f2b8d1085a9d.svg) | 5-(3-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_d49aeab01cd899d863f3eb9336608db1.svg) | 5-(4-Tert-butylphenyl)-9-methyl-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 31800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_74b97e9195937b9dacd707a0d770af4d.svg) | 1-[3-(3-Imidazol-1-ylpropoxy)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylpropan-2-one | Ki | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_732f79d5b6c4bea0c1f5676b76038e16.svg) | 5-(4-Ethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 6300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_9f996cad68cebb9876d74c5daea8c693.svg) | 5-(4-Tert-butylphenyl)-9-chloro-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 40400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_337d38fd017dcffc2d81b7a851987521.svg) | 5-Pyridin-3-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_98996970f0b1fb369bee9a77c47bb7da.svg) | 5-(3,4-Dichloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 17000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_449f5a4ece4b77a0ab65dfd0681a093a.svg) | 5-(3-Trifluoromethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 19200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_14f3280711bc757ddcfc8f2368ea50ee.svg) | 3-[2-[2-(3-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_a62f1640d99106be179e6d06c8f0ac6b.svg) | 3-[2-[2-(4-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_728fe88d2a13d6006d0384cc53e5f170.svg) | 1-Butyl-1-hydroxy-3-[3-methoxy-2-[2-(2,3,5,6-tetrafluorophenyl)sulfanylethoxy]-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]urea | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_25480f21170c563b5441240c6393745a.svg) | 4-[2-(4-Butylphenyl)ethyl]-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_258282ebf854ae4494e676d30b007886.svg) | 3-[2-[2-(2-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 23.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_8e42878b1d281545ab33642d3652ca57.svg) | 1-Butyl-1-hydroxy-3-[3-methoxy-2-[2-(2,3,5,6-tetrafluorophenyl)sulfonylethoxy]-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]urea | IC50 | 285.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_08eebd2fbed5c10ba4458e843a57cdeb.svg) | 1-Butyl-3-[[2-[2-(4-chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxyurea | IC50 | 167.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_0e537f4a589b4d5c8746b507fb9fc6be.svg) | 7-(2-Chlorophenyl)-13-methyl-4-[2-[4-(2-methylpropyl)phenyl]ethyl]-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_688eef7da6c22f15430cf4daeb031a52.svg) | 3-[2-[2-(4-Bromophenyl)sulfonylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 38.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-activating-factor-receptor_6af661a5b8b0f46dce4a25387a0d5321.svg) | 1-Butyl-3-[2-[2-(3,4-dichlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-hydroxyurea | IC50 | 45.0 [1] |